Unknown

Dataset Information

0

Thyroxine Affects Lipopolysaccharide-Induced Macrophage Differentiation and Myocardial Cell Apoptosis via the NF-?B p65 Pathway Both In Vitro and In Vivo.


ABSTRACT: Background:Numerous studies have demonstrated that the inflammatory response is involved in the progression of lipopolysaccharide- (LPS-) induced myocardial cell apoptosis. Accumulating evidence has shown that thyroxine participates in diseases by downregulating the inflammatory response. This study aimed at investigating whether thyroxine alleviates LPS-induced myocardial cell apoptosis. Methods:Bone marrow-derived macrophages (Mø) were treated with LPS and thyroxine, and Mø differentiation and Mø-related cytokine expression were measured. The effect of Mø differentiation on mouse cardiomyocyte (MCM) apoptosis was also detected in vitro. In addition, C57BL/6 mice underwent thyroidectomy and were treated with LPS 35 days later; subsequently, Mø differentiation and myocardial cell apoptosis in hearts were analyzed. To determine whether the nuclear factor-kappa B (NF-?B) p65 pathway mediates the effect of thyroxine on Mø differentiation and myocardial cell apoptosis, the specific NF-?B p65 pathway inhibitor JSH-23 was administered to mice that underwent a thyroidectomy. Results:Levothyroxine treatment significantly reduced the activation of the NF-?B p65 pathway, decreased M1 macrophage (Mø1) differentiation and Mø1-related cytokine mRNA levels in LPS-treated Mø, and increased M2 macrophage (Mø2) differentiation and Mø2-related cytokine mRNA expression. The protective effects of levothyroxine on MCM apoptosis mediated by LPS-treated Mø were alleviated by JSH-23. In mice, thyroidectomy aggravated LPS-induced cardiac injury and cardiac dysfunction, further promoted NF-?B p65 activation, and increased cardiac Mø1 expression and myocardial cell apoptosis but decreased cardiac Mø2 expression. JSH-23 treatment significantly ameliorated the thyroidectomy-induced increases in myocardial cell apoptosis and Mø differentiation. Conclusions:Thyroxine alleviated the Mø1/Mø2 imbalance, reduced the inflammatory response, decreased myocardial cell apoptosis, and protected against cardiac injury and cardiac dysfunction in LPS-treated mice. Thyroxine may be a novel therapeutic strategy to prevent and treat LPS-induced cardiac injury.

SUBMITTER: Zhu S 

PROVIDER: S-EPMC6537024 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

altmetric image

Publications

Thyroxine Affects Lipopolysaccharide-Induced Macrophage Differentiation and Myocardial Cell Apoptosis via the NF-<i>κ</i>B p65 Pathway Both In Vitro and In Vivo.

Zhu Shan S   Wang Yuan Y   Liu Hongtao H   Wei Wen W   Tu Yi Y   Chen Chuang C   Song Junlong J   Xu Zhiliang Z   Li Juanjuan J   Wang Changhua C   Sun Shengrong S  

Mediators of inflammation 20190514


<h4>Background</h4>Numerous studies have demonstrated that the inflammatory response is involved in the progression of lipopolysaccharide- (LPS-) induced myocardial cell apoptosis. Accumulating evidence has shown that thyroxine participates in diseases by downregulating the inflammatory response. This study aimed at investigating whether thyroxine alleviates LPS-induced myocardial cell apoptosis.<h4>Methods</h4>Bone marrow-derived macrophages (Mø) were treated with LPS and thyroxine, and Mø diff  ...[more]

Similar Datasets

| S-EPMC1482593 | biostudies-literature
| S-EPMC9106140 | biostudies-literature
| S-EPMC4633404 | biostudies-literature
| S-EPMC129781 | biostudies-literature
| S-EPMC98226 | biostudies-literature
| S-EPMC5542264 | biostudies-literature
2010-01-10 | GSE15196 | GEO
2010-04-08 | E-GEOD-15196 | biostudies-arrayexpress
| S-EPMC3002872 | biostudies-literature
| S-EPMC5467387 | biostudies-literature